What is the official ID of this bill?

The official print number for this legislation is HR 124.

When did the legislative process begin?

The process officially started on 2023-01-09.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr124/BILLS-118hr124ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Who is the primary sponsor?

The primary sponsor is Rep. Green, Al [D-TX-9].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 124

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Kidney Cancer Education for Sickle Cell Patients on Medicaid

Q: What are the main provisions?

Key points include: Increased health awareness: Sickle cell patients on Medicaid will receive more information about the risk of renal medullary carcinoma. Support for medical education: The act encourages healthcare facilities to provide educational activities in this area. Improved healthcare: Better information can lead to earlier detection and treatment of the disease.

This act aims to raise awareness about renal medullary carcinoma in individuals with sickle cell disease who receive Medicaid medical assistance. It provides incentives for healthcare providers to educate these patients about the risk of this specific cancer. This will help at-risk individuals be better informed about potential health threats.

Key points

Increased health awareness: Sickle cell patients on Medicaid will receive more information about the risk of renal medullary carcinoma.

Support for medical education: The act encourages healthcare facilities to provide educational activities in this area.

Improved healthcare: Better information can lead to earlier detection and treatment of the disease.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Print number: HR 124

Sponsor: Rep. Green, Al [D-TX-9]

Process start date: 2023-01-09

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Kidney Cancer Education for Sickle Cell Patients on Medicaid

Key Questions about Kidney Cancer Education for Sickle Cell Patients on Medicaid